Nras-mutant Melanoma
📧 Sign up to get email alerts when something new happens for Nras-mutant Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma [NA]
A completed clinical trial update evaluating MEK inhibition with autophagy inhibition in metastatic NRAS-mutant melanoma.
-
FDA approval · 2018-06-27FDA Approved: MEKTOVI — Original Application (Array BioPharma Inc.)
FDA approved MEKTOVI (binimetinib) via an original NDA for unresectable or metastatic NRAS-mutant melanoma, marking the initial approval of …